ArticleJournal of nanobiotechnology2026
Selective access to individual cells after assembling for advanced cell-cell interaction studies.
Article in Journal of nanobiotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Understanding the mechanisms underlying cell-cell interactions necessitates a versatile method to assemble cells in a precisely-controlled, cell-specific environment, enabling analysis with high spatiotemporal resolution. Here, we introduce a microfluidic technique using stacked flows to create "virtual" channels under constant or pulsatile flow conditions, supporting various assembly geometries, e.g., doublets and triplets of cells with similar or different sizes, while maintaining independent access to each cell. We demonstrate the method using cell lines and primary human cells within the physiological context of immune cell interactions. Selective access to individual cell types is demonstrated with different molecules: fluorescent dyes for staining the nucleus and plasma membrane and to follow cell activity, antibodies for specific molecular targeting, and calcium ionophores to stimulate cellular activity. As shown by real-time observation of early immune-cell activation following immunological synapse formation between T lymphocytes and leukemic cells, this platform provides a powerful tool for analyzing cell-cell interactions and holds strong potential for fundamental research and clinical applications in precision medicine, drug testing, and disease monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.